Marian K Bakker

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. ncbi request reprint Selection of controls in case-control studies on maternal medication use and risk of birth defects
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 79:652-6. 2007
  2. doi request reprint First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 88:94-100. 2010
  3. doi request reprint Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:808-13. 2010
  4. pmc P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
    Aizati N A Daud
    Unit of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    Drug Saf 38:651-9. 2015
  5. doi request reprint Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection
    Linda de Jonge
    EUROCAT Registration Northern Netherlands, Department of Genetics, University Medical Center Groningen, PO Box 30 001, 9700 RB, Groningen, The Netherlands
    Drug Saf 36:1069-78. 2013
  6. doi request reprint The role of maternal-fetal cholesterol transport in early fetal life: current insights
    Maria E Baardman
    EUROCAT Registration, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Biol Reprod 88:24. 2013
  7. pmc Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Br J Clin Pharmacol 65:600-6. 2008
  8. pmc Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
    Linda de Jonge
    University of Groningen, University Medical Center Groningen, Department of Genetics, EUROCAT Registration Northern Netherlands, Groningen, The Netherlands
    Drug Saf 38:737-47. 2015
  9. doi request reprint Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins
    Aizati N A Daud
    Unit of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, 9713AV Groningen, The Netherlands
    Pharmacogenomics 15:1029-41. 2014
  10. doi request reprint Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study
    Linda de Jonge
    University of Groningen, University Medical Center Groningen, Department of Genetics, EUROCAT Registration Northern Netherlands, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 23:60-8. 2014

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Selection of controls in case-control studies on maternal medication use and risk of birth defects
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 79:652-6. 2007
    ..The aim of this study is to investigate whether first trimester drug use among mothers of children with genetic disorders is representative for the "general pregnant population"...
  2. doi request reprint First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 88:94-100. 2010
    ..There is a need for case-control studies of the effect of paroxetine on the occurrence of specific heart defects...
  3. doi request reprint Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:808-13. 2010
    ..We report an association found in a surveillance study which systematically evaluated combinations of specific birth defects and drugs used in the first trimester of pregnancy...
  4. pmc P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
    Aizati N A Daud
    Unit of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    Drug Saf 38:651-9. 2015
    ..We aim to identify whether drug interactions associated with P-gp promote any changes in fetal drug exposure, as measured by the risk of having children with congenital anomalies...
  5. doi request reprint Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection
    Linda de Jonge
    EUROCAT Registration Northern Netherlands, Department of Genetics, University Medical Center Groningen, PO Box 30 001, 9700 RB, Groningen, The Netherlands
    Drug Saf 36:1069-78. 2013
    ..The effects of many drugs on the unborn child are unknown. In a case-population design, drug exposure of cases is compared with that of a source population; this kind of study can be useful for generating signals...
  6. doi request reprint The role of maternal-fetal cholesterol transport in early fetal life: current insights
    Maria E Baardman
    EUROCAT Registration, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Biol Reprod 88:24. 2013
    ....
  7. pmc Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Br J Clin Pharmacol 65:600-6. 2008
    ..However, the extent of SSRI use in pregnancy is largely unknown...
  8. pmc Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
    Linda de Jonge
    University of Groningen, University Medical Center Groningen, Department of Genetics, EUROCAT Registration Northern Netherlands, Groningen, The Netherlands
    Drug Saf 38:737-47. 2015
    ..We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whether medicines used during pregnancy are taken according to the prescribed dosage and duration...
  9. doi request reprint Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins
    Aizati N A Daud
    Unit of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, 9713AV Groningen, The Netherlands
    Pharmacogenomics 15:1029-41. 2014
    ..The last section looks into the recent studies exploring the association between P-glycoprotein polymorphisms and the risk of fetal birth defects associated with medication use during pregnancy. ..
  10. doi request reprint Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study
    Linda de Jonge
    University of Groningen, University Medical Center Groningen, Department of Genetics, EUROCAT Registration Northern Netherlands, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 23:60-8. 2014
    ..To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16-year period in the Netherlands, and to determine whether they were prescribed according to national guidelines...
  11. ncbi request reprint The cardiac phenotype in patients with a CHD7 mutation
    Nicole Corsten-Janssen
    Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
    Circ Cardiovasc Genet 6:248-54. 2013
    ..We present the first, detailed, descriptive study on the cardiac phenotype of 299 patients with a CHD7 mutation and discuss the role of CHD7 in cardiac development...
  12. doi request reprint Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction?
    Maria E Baardman
    EUROCAT Northern Netherlands, Department of Medical Genetics, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands
    Heart 98:474-9. 2012
    ..To study the influence of a possible interaction between maternal smoking and high body mass index (BMI) on the occurrence of specific congenital heart anomalies (CHA) in offspring...
  13. pmc The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands
    Katelijne Bouman
    University of Groningen, University Medical Center Groningen, Department of Genetics, PO Box 30001, 9700 RB, Groningen, The Netherlands
    BMC Pregnancy Childbirth 17:4. 2017
    ..To evaluate the impact of the introduction of prenatal screening on time of detection and pregnancy outcome for trisomy 21 (T21), trisomy 18 (T18) and trisomy 13 (T13)...
  14. doi request reprint Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Janneke Jentink
    Pharmacoepidemiology and Pharmacoeconomics, SHARE, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:803-7. 2010
    ..However, there is less evidence for this protective effect in women using valproic acid (VPA). We investigated the effect of folic acid in women exposed to VPA in the first trimester of pregnancy...
  15. doi request reprint Survival and health in liveborn infants with transposition of great arteries--a population-based study
    Ester Garne
    Paediatric Department, Kolding Hospital, Kolding, Denmark
    Congenit Heart Dis 2:165-9. 2007
    ..To describe treatment, survival, and morbidity for liveborn infants with isolated transposition of great arteries (TGA)...